Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05600803
What this trial is testing

Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions

Who this might be right for
CholangiocarcinomaBile Duct Neoplasms
Soonchunhyang University Hospital 236
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946849
What this trial is testing

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital 76
Not applicableNo Longer AvailableNCT03414489
What this trial is testing

Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

Who this might be right for
CholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more
RedHill Biopharma Limited
Testing effectiveness (Phase 2)UnknownNCT00003296
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Brown University 26
Not applicableUnknownNCT03102268
What this trial is testing

NcRNAs in Exosomes of Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBenign Biliary Stricture
The Second Hospital of Nanjing Medical University 80
Testing effectiveness (Phase 2)Ended earlyNCT02415036
What this trial is testing

Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma

Who this might be right for
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 17
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT05010681
What this trial is testing

Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Early research (Phase 1)Study completedNCT03821233
What this trial is testing

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Who this might be right for
HER2-expressing Cancers
Zymeworks BC Inc. 112
Not applicableUnknownNCT04386772
What this trial is testing

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Who this might be right for
Portal Vein OcclusionCholangiocarcinoma, PerihilarHepatocellular Carcinoma+1 more
Eastern Hepatobiliary Surgery Hospital 56
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Testing effectiveness (Phase 2)Looking for participantsNCT06664021
What this trial is testing

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Anhui Provincial Hospital 60
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableEnrolling By InvitationNCT06997913
What this trial is testing

Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）

Who this might be right for
Lymph Node MetastasisNeurovascular InvasionPathology Showed R1 Resection
Hengchao Yu 10
Testing effectiveness (Phase 2)Study completedNCT01718327
What this trial is testing

Sunitinib in Patients With Advanced Cholangiocarcinoma

Who this might be right for
Unresectable and Advanced Cholangiocarcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group 53
Not applicableLooking for participantsNCT01915225
What this trial is testing

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Who this might be right for
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinoma+2 more
National Cancer Institute (NCI) 1,800
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03212274
What this trial is testing

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
Advanced Malignant Solid NeoplasmGlioblastomaRecurrent Cholangiocarcinoma+4 more
National Cancer Institute (NCI) 89
Testing effectiveness (Phase 2)Study completedNCT01534637
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerNauseaVomiting+3 more
Wake Forest University Health Sciences 22
Next Page